Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

The study found unique skin changes in a rare type of alopecia linked to a skin condition called linear morphea.

Vitamin C was found to effectively treat prickly heat in children.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

Soy hull supplementation did not affect sheep gastrointestinal parasite infection compared to corn-based supplements.

Lower LDL-c levels predict higher COVID-19 mortality.

SHISA6 helps maintain certain stem cells in mouse testes by blocking signals that would otherwise cause them to differentiate.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.